National Academies Press: OpenBook
« Previous: Appendix A Bibliography of Related National Academies Reports
Suggested Citation:"Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
×

B
Methods

The committee developed this interim report and arrived at conclusions and recommendations regarding the strengths and weaknesses of the Bioastronautics Roadmap (BR) during a 13-month period from April 2004 to May 2005. During this time, the committee held four data-gathering sessions; made one site visit to the Johnson Space Center in Houston, Texas; and met in closed session seven times to deliberate. Agendas for the open, data-gathering sessions of these meetings are included in this appendix.

Suggested Citation:"Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
×

INSTITUTE OF MEDICINE

AGENDA

Committee on Aerospace Medicine and Medicine in Extreme Environments

and

Committee on Review of NASA’s Bioastronautics

Critical Path Roadmap

Keck Building

500 5th Street, NW

Washington, DC

Room 110

Monday, April 12, 2004

CLOSED SESSION

(committee and staff only)

8:00 a.m.–12:00 p.m.

OPEN SESSION

12:00 p.m.

Lunch

1:00 p.m.

Request for a review of the Bioastronautics Critical Path Roadmap (BCPR)

Richard Williams, M.D., Chief Health and Medical Officer, NASA

1:10 p.m.

Overview of the Bioastronautics Critical Path Roadmap

NASA presenters: Guy Fogleman, director of bioastronautics research, Office of Biological and Physical Research; Howard Ross, acting deputy associate administrator for science, Office of Biological and Physical Research; Marc Shepanek, deputy chief, Medicine of Extreme Environments, NASA; Frank Sulzman, manager, Space Radiation Health Project

1:20 p.m.

How the Bioastronautics Critical Path Roadmap captures the critical risks and key research and technology issues for risk reduction, management, and informed decision making

Suggested Citation:"Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
×

1:40 p.m.

The Bioastronautics Critical Path Roadmap’s method and expression of risk assessment for medical decision making and the BCPR communication of these methods for different mission scenarios

2:20 p.m.

Types of risks and impacts of risk as expressed in the Bioastronautics Critical Path Roadmap

3:00 p.m.

Break

3:30 p.m.

Categories of critical research issues and metrics used in the Bioastronautics Critical Path Roadmap

4:10 p.m.

Efficiency and technology issues in the Bioastronautics Critical Path Roadmap

4:50 p.m.

Plenary discussion

Led by David Longnecker, M.D.

5:30 p.m.

Adjourn to reception and dinner with invited guests

Location: third floor atrium

Tuesday, April 13, 2004

OPEN SESSION

8:00 a.m.

Continental breakfast

8:30 a.m.

Welcoming remarks

David Longnecker, M.D.

8:45 a.m.

Overview of related work by the National Academies

9:00 a.m.

Space Studies Board/ASEB

9:30 a.m.

CAMMEE

10:00 a.m.

Break

CLOSED SESSION

(committee and staff only)

10:15 a.m.–3:30 p.m.

Suggested Citation:"Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
×

INSTITUTE OF MEDICINE

AGENDA

Committee on Review of NASA’s Bioastronautics

Critical Path Roadmap

Keck Building

500 5th Street, NW

Washington, DC

Room 204

Wednesday, June 9, 2004

OPEN SESSION

9:00 a.m.

Welcome and overview of day’s agenda

David Longnecker, M.D., and Lisa Vandemark, Ph.D.

9:15 a.m.

Briefings related to the review of the Bioastronautics Critical Path Roadmap

NASA presenters: Lauren Leveton, Bioastronautics Science Management Team, NASA; Holly Patton, Aerospace Technologist, NASA; David Tomko, Lead Scientist, Biomedical Program, BASA Bioastronautics Research Division; Guy Fogleman, Director of Bioastronautics Research, Office of Biological and Physical Research; Frank Sulzman, Manager, Space Radiation Health Project

12:00 p.m.

Lunch

1:00 p.m.

Bone loss and countermeasures: historical perspectives and new in-flight clinical studies

Jay Shapiro, M.D., Uniformed Services University of the Health Sciences

2:00 p.m.

Harmonization of crew living module and extravehicular pressure suit atmospheric constituents and pressures

Bruce McCandless, M.S., M.B.A., Lockheed Martin

3:00 p.m.

Break

3:30 p.m.

An overview of space biology from cells to humans

David Klaus, Ph.D., University of Colorado, Boulder

4:30 p.m.

Plenary discussion

Led by David Longnecker, M.D.

5:30 p.m.

Adjourn

Suggested Citation:"Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
×

Thursday, June 10, 2004

CLOSED SESSION

(committee and staff only)

8:30 a.m.–3:00 p.m.

INSTITUTE OF MEDICINE

AGENDA

Committee on Review of NASA’s Bioastronautics

Critical Path Roadmap

Keck Building

500 5th Street, NW

Washington, DC

Room 201

Monday, August 2, 2004

OPEN SESSION

9:00 a.m.

Welcome, introductions, and overview of day’s agenda

David Longnecker, M.D., and Lisa Vandemark, Ph.D.

9:20 a.m.

Briefings related to the review of the Bioastronautics Critical Path Roadmap

Richard Williams, M.D.

10:30 a.m.

Break

11:00 a.m.

Briefings related to the review of the Bioastronautics Critical Path Roadmap

NASA presenters via videoconference from Johnson Space Center: Guy Fogleman, Director of Bioastronautics Research, Office of Biological and Physical Research; Marc Shepanek, Deputy Chief, Medicine of Extreme Environments, NASA; Desmond Lugg, Chief, Medicine of Extreme Environments, Office of the Chief Medical Officer

11:30 a.m.

Question-and-answer discussion

David Longnecker, M.D., Moderator

12:00 p.m.

Lunch

Suggested Citation:"Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
×

1:00 p.m.

Advanced life support issues

Brian Dunaway, Boeing Corporation

CLOSED SESSION

(committee and staff only)

2:30 p.m.–5:30 p.m.

Tuesday, August 3, 2004

CLOSED SESSION

(committee and staff only)

8:30 a.m.–3:00 p.m.

INSTITUTE OF MEDICINE

AGENDA

Committee on Review of NASA’s Bioastronautics

Critical Path Roadmap

National Academy of Sciences Building

2101 Constitution Avenue, NW

Washington, DC

Lecture Room

Monday, January 31, 2005

OPEN SESSION

9:00 a.m.

Welcome and introductions

David E. Longnecker, M.D., Chair

9:20 a.m.

Overview of the day’s agenda

Lisa M. Vandemark, Ph.D., Study Director

9:30 a.m.

Guest presentations

Admiral Walter Cantrell, NASA Headquarters; Joseph Genovese, Hamilton Sunstrand; Joseph Fuller, Futron Corporation

12:00 p.m.

Lunch

Suggested Citation:"Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
×

1:00 p.m.

Guest presentations

Geoffrey McIntyre, Federal Aviation Administration; Michael Gernhardt, NASA Johnson Space Center; Alan Feiveson, NASA Johnson Space Center (via phone conference); William Stone, Stone Aerospace

3:15 p.m.

Break

4:00 p.m.

Overview of the new Bioastronautics Roadmap

Lauren Leveton, Ph.D., NASA Headquarters

4:30 p.m.

Plenary discussion

Led by David Longnecker, M.D.

5:30 p.m.

Adjourn

Tuesday, February 1, 2005

CLOSED SESSION

(committee and staff only)

Suggested Citation:"Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
×

This page intentionally left blank.

Suggested Citation:"Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
×
Page 89
Suggested Citation:"Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
×
Page 90
Suggested Citation:"Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
×
Page 91
Suggested Citation:"Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
×
Page 92
Suggested Citation:"Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
×
Page 93
Suggested Citation:"Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
×
Page 94
Suggested Citation:"Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
×
Page 95
Suggested Citation:"Appendix B Methods." Institute of Medicine and National Research Council. 2006. A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press. doi: 10.17226/11467.
×
Page 96
Next: Appendix C Status of Countermeasure and Technology Readiness Levels »
A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap Get This Book
×
Buy Paperback | $52.00 Buy Ebook | $41.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Extending the spatial and temporal boundaries of human space flight is an important goal for the nation and for the National Aeronautics and Space Administration (NASA). However, human space flight remains an endeavor with substantial risks, and these risks must be identified, managed, and mitigated appropriately to achieve the nation's goals in space. The Bioastronautics Roadmap (BR) is the result of extensive, commendable efforts on the part of NASA to prioritize research efforts to meet these challenges.

In 2003, NASA asked the Institute of Medicine (IOM), in collaboration with the Division on Engineering and Physical Sciences of the National Academies, to conduct a review of the BR. Specifically, NASA asked the committee to (1) conduct a comprehensive assessment and report of the strengths and weaknesses of the content and processes of the Bioastronautics Roadmap as applied to the missions described in the President's exploration initiative and (2) identify the unique challenges for accomplishing its goals and objectives.

In September 2004, the committee released its preliminary report to NASA entitled Preliminary Considerations Regarding NASA's Bioastronautics Critical Path Roadmap. That document presented the committee's preliminary conclusions about the strengths and weaknesses of the April 2004 version of the BR. This report, A Risk Reductions Strategy for Human Exploration of Space, builds on those preliminary conclusions and provides recommendations to NASA about how to address the issues identified by the committee.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!